AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 121 min read$ALHC

KAO JOHN E sold $4.9M of ALHC

KAO JOHN E (Chief Executive Officer) sold 385,270 shares of Alignment Healthcare, Inc. (ALHC) at $12.68 ($4.89M total) on 2026-09-11 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · KAO JOHN E
Published Sep 12, 2026, 12:38 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 12, 2026, 1:01 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ALHC
Bearish
medium confidence
Mentioned
$ALHC
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALHCBearishMed
01

Why it matters

The sale represents a $4.9M reduction in CEO holdings, which may be interpreted by investors as a bearish sign.

02

Market read

Insider sales are closely watched; this filing could influence short-term price action.

03

What to watch

Pre-arranged 10b5-1 plans are often used for tax planning and may not reflect sentiment.

Relevance 5/10Novelty 7/10Timing: after-market 2026-09-11

Background

Form 4 filing discloses insider transactions required by SEC; provides first public notice of the sale.

Company-level read

Ticker impact

$ALHCBearishMedium confidence
Context

CEO sold 385,270 shares for $4.9M via 10b5-1 plan on 2026-09-11

Expected impact

Potential modest downside pressure in near-term trading.

Evidence & confidence

Large insider sell by CEO, executed under pre-arranged plan, indicates possible liquidity need or valuation concerns.

Market effects

Sector

May affect healthcare services sector sentiment as insider activity is monitored.

Regional

Limited to US markets where ALHC trades.

Global

Low

Counterpoint

What could challenge this read

Insider sale could be routine liquidity event, not a negative signal.

Key entities

  • Officer
    KAO JOHN E

    Chief Executive Officer of Alignment Healthcare, Inc.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ALHC insider trading history →

Related articles

SEP 21
$ALHCMed

Alignment Shares Tumble on Rising Medical Costs

Alignment Healthcare (ALHC) shares fell 16% after executives cited rising medical costs and claims system issues. CEO John Kao noted the company is addressing these challenges. Despite a 47% drop in the past year, the company maintained its revenue guidance. TD Cowen reiterated a Buy rating with a $21 price target. Alignment is expanding its network with Hoag Memorial Hospital.

ocbj.com2 min
SEP 18
$ALHCMed

ALHC Stock Slides As Legal And Cost Pressures Mount

Alignment Healthcare Inc. (ALHC) shares fell 3.61% on September 18, 2026, due to investor concerns over Medicare Advantage reimbursement and regulatory pressures. The stock has dropped significantly from $13–$14 to around $8.35, with technical damage and high volatility. Management cited Q3 medical cost headwinds and additional investments, while a whistleblower alleged expense misclassification, leading to legal probes. Insider selling and weak sentiment have further pressured the stock.

stockstotrade.com2 min
SEP 16
$ALHCMed

Alignment Healthcare extends retreat, falls an additional 16% (ALHC:NASDAQ)

Alignment Healthcare (ALHC) shares fell 16% on Wednesday, extending a 20% drop from the prior session. Management cited planned investments and medical-cost pressures at the Baird 2026 Global Healthcare Conference. The stock reached a 52-week low at $8.71, trading 45-54% below its 50/200-day averages. An analyst upgraded ALHC to Buy, noting operational progress but warning of potential volatility.

seekingalpha.com1 min
SEP 15
$ASTHMed

Astrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To Know

Several healthcare stocks fell after bipartisan lawmakers introduced the Protecting Approved Care Act, which aims to reform Medicare Advantage plans. The bill could increase medical loss ratios and administrative burdens for insurers. Astrana Health (ASTH) fell 2.7%, Clover Health (CLOV) 4.8%, Alignment Healthcare (ALHC) 12.6%, and Novavax (NVAX) 3.6%.

financialcontent.com2 min
SEP 15
$ALHCMed

ALHC Stock Tumbles After ‘Don’t Poke the Bear’ Silence On Star Ratings — CLOV Falls With It

Alignment Healthcare (ALHC) shares dropped 22% after executives declined to discuss next year's quality bonus and noted higher-than-expected hospital bills. CEO John Kao cited CMS sensitivity about commenting on Plan Preview 2. Clover Health (CLOV) also fell 9%. ALHC's CFO mentioned institutional cost headwinds but expects them to ease by 2027. Guidance remained unchanged.

stocktwits.com2 min
SEP 10
$PGNYHighAI 8/10

Spotting Winners: Progyny (NASDAQ:PGNY) And Health Insurance Providers Stocks In Q2

Progyny (PGNY) and other health insurers reported Q2 earnings, with revenues beating estimates by 2.8% but guidance below expectations. PGNY's revenue grew 5.3% YoY, missing EBITDA guidance. CVS Health (CVS) reported 7.3% YoY revenue growth, beating estimates. Molina Healthcare (MOH) saw a 4.8% YoY revenue decline. Alignment Healthcare (ALHC) grew 31.6% YoY, while Clover Health (CLOV) saw 55.6% YoY growth. Stocks have declined since earnings, except CLOV, which rose 4.3%.

tradingview.com3 min